Dan Ebner
banner
danebner.bsky.social
Dan Ebner
@danebner.bsky.social
Holman @MayoRadOnc, AI/ML @MITCriticalData, heavy-ion research with @QST_Japan
Reposted by Dan Ebner
You: But I don't know what to do with a super-smart AI capable of conducting graduate-level research.

Me:
February 4, 2025 at 7:05 AM
Reposted by Dan Ebner
New randomized, controlled trial by the World Bank of students using GPT-4 as a tutor in Nigeria. Six weeks of after-school AI tutoring = 2 years of typical learning gains, outperforming 80% of other educational interventions.

And it helped all students, especially girls who were initially behind.
January 15, 2025 at 8:58 PM
Reposted by Dan Ebner
Patient satisfaction is important. But medicine involves tough topics & hard decisions.
-Treating provider & restaurant reviews the same is a mistake.
-Obsession over fractions of pct points in satisfaction is unequivocally negatively impacting provider burnout.

www.doximity.com/newsfeed/ab5...
Online Reviews: A Growing Threat to Physician Morale and Patient Care
One of the naive missteps I took shortly after transitioning from trainee into an attending role was to sign up for Google to alert me whenever one...
www.doximity.com
December 29, 2024 at 2:00 PM
Reposted by Dan Ebner
Health insurance industry PR is working overtime right now diverting blame to physicians for claim denials and rising costs. I feel compelled to remind everybody that Optum (UHC) is the largest employer of physicians in the US. We have never had less power in healthcare than we do right now.
December 12, 2024 at 6:03 PM
Reposted by Dan Ebner
Sometimes our anthropocentric assumptions about how intelligence "should" work (like using language for reasoning) may be holding AI back. Letting AI reason in its own native "language" in latent space could unlock new capabilities, improving reasoning over Chain of Thought. arxiv.org/pdf/2412.06769
December 10, 2024 at 2:59 PM
Reposted by Dan Ebner
On the heels of the Ph2 trial out of Mayo using iv Lu-DOTATATE recurrent/refractory meningioma, this study shows promise using Intraarterial Lu-DOTATATE!

Repurposing existing agents and testing new modes of administration!

#radonc #nucmed #radiopharmaceuticals

jnm.snmjournals.org/content/65/1...
Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy
Peptide receptor radionuclide therapy (PRRT) is a treatment option for patients with advanced meningioma. Recently, intraarterial application of the radiolabeled somatostatin receptor agonists has bee...
jnm.snmjournals.org
December 4, 2024 at 12:15 PM
still throwing me off that bluesky.com is a daily planner website.
Blue Sky | 2025 Daily, Weekly, and Monthly Planners
The Blue Sky planner is the solution to your planning needs. Select from our assortment of 2025 daily, weekly, and monthly planners for the new year!
bluesky.com
December 4, 2024 at 2:18 PM
Reposted by Dan Ebner
FLASH Bragg-peak irradiation with a therapeutic carbon ion beam: first in vivo results
www.sciencedirect.com/science/arti...
FLASH Bragg-peak irradiation with a therapeutic carbon ion beam: first in vivo results
In recent years, ultra-high dose rate (UHDR) irradiation has emerged as a promising innovative approach to cancer treatment. Characteristic feature of…
www.sciencedirect.com
November 27, 2024 at 11:45 AM
Reposted by Dan Ebner
November 26, 2024 at 4:01 PM